Zai Lab

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zai Lab and other ETFs, options, and stocks.

About ZLAB

Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. 

CEO
Ying Du
CEOYing Du
Employees
1,869
Employees1,869
Headquarters
Shanghai, Shanghai
HeadquartersShanghai, Shanghai
Founded
2014
Founded2014
Employees
1,869
Employees1,869

ZLAB Key Statistics

Market cap
3.64B
Market cap3.64B
Price-Earnings ratio
-16.02
Price-Earnings ratio-16.02
Dividend yield
Dividend yield
Average volume
1.16M
Average volume1.16M
High today
$32.72
High today$32.72
Low today
$31.70
Low today$31.70
Open price
$32.68
Open price$32.68
Volume
503.55K
Volume503.55K
52 Week high
$44.34
52 Week high$44.34
52 Week low
$20.17
52 Week low$20.17

ZLAB News

TipRanks 3d
Top Executive Makes Bold Move with Major Stock Purchase!

New insider activity at Zai Lab ( (ZLAB) ) has taken place on September 12, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% o...

Simply Wall St 6d
Why Zai Lab Is Down 5.5% After Diminished Final Results for Bemarituzumab in Gastric Cancer

In early September 2025, Zai Lab announced that the final analysis of its Phase 3 FORTITUDE-101 trial in gastric cancer indicated the previously reported surviv...

Why Zai Lab Is Down 5.5% After Diminished Final Results for Bemarituzumab in Gastric Cancer

Analyst ratings

86%

of 14 ratings
Buy
85.7%
Hold
14.3%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.